Foot News and Research

RSS

Women making poor shoe choices suffer with hindfoot pain

A recently published study determined that women who make poor shoe choices early in life suffer with foot pain in later years. Research shows that men do not experience the same foot pain as women, due to type of shoes they wear. Details of this study appear in the October issue of Arthritis Care & Research, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology.

30 Sep 2009

Finance Senators picking sides as panel continues health bill markup

Politico: "Senate Finance Committee Chairman Max Baucus faces multiple challenges as he gavels in another week of work on health care Tuesday. High on the list: controlling the drama in the hearing room."

30 Sep 2009

Hanford Pharmaceuticals expands into new business areas

On September 24, 2009, Hanford Pharmaceuticals (“Hanford” or the “Company”) completed the sale of its Cephalosporin manufacturing facility in Syracuse, NY, an asset that had been under-performing for quite some time.l

29 Sep 2009

Proton therapy center to treat pediatric and adult cancer patients

The development of a proton therapy center in the Pacific Northwest has taken a significant step forward with the signing of a letter of intent between the Seattle Cancer Care Alliance (SCCA) and ProCure Treatment Centers Inc. (ProCure). SCCA and ProCure announced the agreement today and are moving the project forward to bring this advanced form of radiation therapy to adult and pediatric cancer patients.

29 Sep 2009

High-heels may lead to heel and ankle pain

Women should think twice before buying their next pair of high-heels or pumps, according to researchers at the Institute for Aging Research of Hebrew SeniorLife in a new study of older adults and foot problems.

29 Sep 2009

The CDH Proton Therapy Center announces arrival of a 220-ton cyclotron for treating cancer

A 220-ton cyclotron, the core of what will soon be Illinois’ most advanced radiation treatment center, has ended a 5,000-mile journey that began in Belgium, arriving at the construction site of the CDH Proton Therapy Center, a ProCure Center, located in suburban Warrenville. Capable of accelerating protons, the cyclotron is the core piece of equipment used in proton therapy, an alternative to X-ray radiation that spares healthy tissue and results in far fewer short- and long-term treatment side effects.

28 Sep 2009

Podiatric experts recommend team approach for diabetic foot care

Every 30 seconds, across the globe an individual loses a limb due to poor diabetes management. In the U.S., diabetes affects nearly 24 million people. When poorly controlled, diabetes results in nerve damage and poor circulation to the legs and feet.

28 Sep 2009

Quintiles opens an expanded regional facility

To enhance service offerings throughout Europe, Quintiles Transnational Corp. today announced the opening of an expanded regional facility near Edinburgh, Scotland. The purpose-built facility consolidates three buildings into a single state-of-the-art complex.

28 Sep 2009

Baylor Health Care receives $20 million donation from Sammons Enterprises

Today the Baylor Health Care System Foundation announced gifts exceeding $20 million for what will be North Texas' largest outpatient cancer center and first dedicated hospital focusing on cancer patients.

25 Sep 2009

Neogen announces first-quarter results of fiscal 2010

Neogen Corporation announced today that its revenues for the first quarter of FY 2010, which ended Aug. 31, increased 12% from the previous year's first quarter to $32,347,000. First quarter net income increased 18% from the prior year's $3,733,000 to $4,395,000, or to $0.29 per share in the current year compared to the previous year's $0.25.

25 Sep 2009

Advanced Biohealing announces growth strategy to expand its product line

Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine, announced a strategic growth plan designed to continue the transformation of this former start-up into the leading international regenerative medicine company.

24 Sep 2009

Results of Phase 3 CRYSTAL study of mCRC patients announced

The retrospective CRYSTAL analysis was conducted as a result of an effort to increase the tissue ascertainment rate to determine the K-ras status of patients’ tumors. The analysis included extended patient follow up of nearly 1.5 years and doubled the tissue ascertainment rate from 45% to 89%. These data are an update from the overall survival results from CRYSTAL that were published in the April 2009 issue of the New England Journal of Medicine.

23 Sep 2009

Phase 2 trial results of Bayer's Nexavar in combination with capecitabine announced

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced the full results from their first collaborative group-sponsored randomized, double-blind, placebo-controlled Phase 2 trial showing that Nexavar(R) (sorafenib) tablets in combination with the oral chemotherapeutic agent, capecitabine, significantly extended progression-free survival in patients with advanced breast cancer.

23 Sep 2009

KARL STORZ receives LEED Silver certification

KARL STORZ Endoscopy-America, Inc., a leader in diagnostic and operative minimally invasive endoscopic technology, is proud to announce that it has been awarded LEED® (Leadership in Energy and Environmental Design) Silver certification from the U.S. Green Building Council (USGBC) for the company’s North American Headquarters.

23 Sep 2009

Bioelectronics files for pre-marketing clearance for its ActiPatch® Therapy products

BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, announced that it filed today with the U.S. Government's Food and Drug Administration for 510(K) pre-marketing clearance for its ActiPatch® Therapy products.

23 Sep 2009

ACR Image Metrix successfully completes two years, looks forward to increased business in third year

ACR Image Metrix™, an imaging contract research organization (CRO), exceeded its goals by initiating projects for over 30 pharmaceutical, biotechnology and medical device companies through its second full year of operation.

23 Sep 2009

Results of OASIS clinical trial reported by Cardiovascular Systems

Two-year follow-up of patients in the first-ever prospective, multi-center clinical trial evaluating a plaque removal product show promising results after treatment with the Diamondback 360® PAD System, a minimally invasive catheter system that removes hardened plaque to restore blood flow in arteries.

23 Sep 2009

Amnesty International report highlights maternal mortality 'emergency' in Sierra Leone

"One in eight women in Sierra Leone risks dying of pregnancy and childbirth complications exacerbated by a combination of poverty, discrimination, inequality and government mismanagement," according to an Amnesty International report, released Tuesday, Reuters AlertNet reports (Fominyen, 9/22).

23 Sep 2009

Alpha Orthotics announces launch of its Medial Mid-foot Brace in the U.S.

Splayfoot, also called "fallen arch" occurs when the arch of the foot collapses, with the entire sole of the foot coming into complete or near-complete contact with the ground. An estimated 20%-30% of Americans have this condition where the arch never develops, or collapses in one or both feet.

23 Sep 2009

'The Dr. Oz Show' and NAFC collaborate to hold an enormous free clinic

"The Dr. Oz Show," the new daily syndicated show hosted by cardiac surgeon and health expert Dr. Mehmet Oz, and the National Association of Free Clinics (NAFC), will hold an enormous free clinic at the Reliant Convention Center in Houston, Texas on Saturday September 26, 2009 to provide medical care to hundreds of people who have no form of basic health insurance.

22 Sep 2009